Chongqing Pharscin Pharmaceutical Co., Ltd.
SHZ: 002907.SZ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shenzhen Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Xiaoying Liu
- Employees
- 1,384
- Headquarters
- Chongqing, China
- IPO year
- 2017
- Market cap
- CN¥5.7B
- Website
- https://www.pharscin.com
Loading 002907…
Loading profile data…Frequently asked questions about 002907
What does Chongqing Pharscin Pharmaceutical Co., Ltd. (002907.SZ) do?
Chongqing Pharscin Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of drugs in China. The company offers tablets, powders, granules, hard capsules, soft capsules, powder injections, freeze-dried powder injections, small volume injections, and API synthesis. It provides its products in the areas of CNS, dige...
Where does 002907.SZ trade?
Chongqing Pharscin Pharmaceutical Co., Ltd. (002907.SZ) trades on the Shenzhen Stock Exchange.
What sector is 002907.SZ in?
Chongqing Pharscin Pharmaceutical Co., Ltd. (002907.SZ) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Chongqing Pharscin Pharmaceutical Co., Ltd.?
Xiaoying Liu is the chief executive officer of Chongqing Pharscin Pharmaceutical Co., Ltd. (002907.SZ).
Where is Chongqing Pharscin Pharmaceutical Co., Ltd. headquartered?
Chongqing Pharscin Pharmaceutical Co., Ltd. is headquartered in China.
Does 002907.SZ pay a dividend?
Yes — Chongqing Pharscin Pharmaceutical Co., Ltd. (002907.SZ) paid a trailing twelve-month dividend of CNY 0.09 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 002907.SZ go public?
Chongqing Pharscin Pharmaceutical Co., Ltd. (002907.SZ) completed its initial public offering in 2017.